Related Experiment Video
Updated: Nov 10, 2025

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
Published on: July 7, 2020
Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane
Akshay Sabnis1, Katheryn Lh Hagart1, Anna Klöckner1,2,3,4
1MRC Centre for Molecular Bacteriology and Infection, Imperial College London, London, United Kingdom.
Abstract:
Colistin is an antibiotic of last resort, but has poor efficacy and resistance is a growing problem. Whilst it is well established that colistin disrupts the bacterial outer membrane (OM) by selectively targeting lipopolysaccharide (LPS), it was unclear how this led to bacterial killing. We discovered that MCR-1 mediated colistin resistance in Escherichia coli is due to modified LPS at the cytoplasmic rather than OM. In doing so, we also demonstrated that colistin exerts bactericidal activity by targeting LPS in the cytoplasmic membrane (CM). We then exploited this information to devise a new therapeutic approach. Using the LPS transport inhibitor murepavadin, we were able to cause LPS accumulation in the CM of Pseudomonas aeruginosa, which resulted in increased susceptibility to colistin in vitro and improved treatment efficacy in vivo. These findings reveal new insight into the mechanism by which colistin kills bacteria, providing the foundations for novel approaches to enhance therapeutic outcomes.
Insights
Colistin resistance is rising. New research shows colistin kills bacteria by targeting lipopolysaccharide (LPS) in the cytoplasmic membrane, not the outer membrane. This discovery enables new therapeutic strategies against resistant bacteria.
Area of Science:
- Microbiology
- Pharmacology
- Biochemistry
Background:
- Colistin is a critical last-resort antibiotic with limitations in efficacy and increasing resistance.
- The precise bactericidal mechanism of colistin, particularly its interaction with bacterial membranes, remained incompletely understood.
- Lipopolysaccharide (LPS) modification, mediated by MCR-1, was identified as a key factor in colistin resistance.
Purpose of the Study:
- To elucidate the exact mechanism by which colistin exerts its bactericidal activity.
- To investigate the role of LPS localization in colistin resistance and susceptibility.
- To develop novel therapeutic strategies for combating colistin-resistant bacterial infections.
Main Methods:
- Investigated MCR-1 mediated colistin resistance in *Escherichia coli*, focusing on LPS modification.
- Determined colistin's bactericidal action by analyzing its interaction with LPS in different cellular compartments (cytoplasmic membrane vs. outer membrane).
- Utilized the LPS transport inhibitor murepavadin to induce LPS accumulation in *Pseudomonas aeruginosa*'s cytoplasmic membrane, followed by colistin treatment.
Main Results:
- Discovered that MCR-1 mediated colistin resistance in *Escherichia coli* is linked to LPS modification in the cytoplasmic membrane, not the outer membrane.
- Demonstrated that colistin's bactericidal effect stems from targeting LPS within the cytoplasmic membrane.
- Showed that inhibiting LPS transport with murepavadin enhances *Pseudomonas aeruginosa*'s susceptibility to colistin in vitro and improves treatment efficacy in vivo.
Conclusions:
- Colistin's primary bactericidal mechanism involves targeting lipopolysaccharide (LPS) in the cytoplasmic membrane.
- LPS modification in the cytoplasmic membrane is crucial for MCR-1 mediated colistin resistance.
- Combining LPS transport inhibition with colistin presents a promising therapeutic strategy to overcome colistin resistance and improve treatment outcomes.
More Related Videos
Related Concept Videos
Biological Methods for Microbial Control
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Formation of Lipopolysaccharides
Bacterial Phylum Planctomycetes
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Drugs that Destabilize Microtubules

